Hypoxia-inducible Factor Signaling Provides Protection in Clostridium Difficile-induced Intestinal Injury
Overview
Authors
Affiliations
Background & Aims: Clostridium difficile is the leading cause of nosocomial infectious diarrhea. Antibiotic resistance and increased virulence of strains have increased the number of C difficile-related deaths worldwide. The innate host response mechanisms to C difficile are not resolved; we propose that hypoxia-inducible factor (HIF-1) has an innate, protective role in C difficile colitis. We studied the impact of C difficile toxins on the regulation of HIF-1 and evaluated the role of HIF-1alpha in C difficile-mediated injury/inflammation.
Methods: We assessed HIF-1alpha mRNA and protein levels and DNA binding in human mucosal biopsy samples and Caco-2 cells following exposure to C difficile toxins. We used the mouse ileal loop model of C difficile toxin-induced intestinal injury. Mice with targeted deletion of HIF-1alpha in the intestinal epithelium were used to assess the effects of HIF-1alpha signaling in response to C difficile toxin.
Results: Mucosal biopsy specimens and Caco-2 cells exposed to C difficile toxin had a significant increase in HIF-1alpha transcription and protein levels. Toxin-induced DNA binding was also observed in Caco-2 cells. Toxin-induced HIF-1alpha accumulation was attenuated by nitric oxide synthase inhibitors. In vivo deletion of intestinal epithelial HIF-1alpha resulted in more severe, toxin-induced intestinal injury and inflammation. In contrast, stabilization of HIF-1alpha with dimethyloxallyl glycine attenuated toxin-induced injury and inflammation. This was associated with induction of HIF-1-regulated protective factors (such as vascular endothelial growth factor-alpha, CD73, and intestinal trefoil factor) and down-regulation of proinflammatory molecules such as tumor necrosis factor and Cxcl1.
Conclusions: HIF-1alpha protects the intestinal mucosa from C difficile toxins. The innate protective actions of HIF-1alpha in response to C difficile toxins be developed as therapeutics for C difficile-associated disease.
Effect of Butyrate on Food-Grade Titanium Dioxide Toxicity in Different Intestinal In Vitro Models.
Becht J, Kohlleppel H, Schins R, Kampfer A Chem Res Toxicol. 2024; 37(9):1501-1514.
PMID: 39213652 PMC: 11409378. DOI: 10.1021/acs.chemrestox.4c00086.
Wirz K, Schulz C, Sobbeler F, Armando F, Beythien G, Gerhauser I Am J Respir Cell Mol Biol. 2024; 71(2):146-153.
PMID: 39087829 PMC: 11299086. DOI: 10.1165/rcmb.2024-0005MA.
Chen W, Huang C, Tang D, Wan J, Zhou X, Wu C Am J Transl Res. 2024; 16(6):2248-2262.
PMID: 39006272 PMC: 11236646. DOI: 10.62347/IHNX2675.
Hypoxia-inducible factor-driven glycolytic adaptations in host-microbe interactions.
DeMichele E, Buret A, Taylor C Pflugers Arch. 2024; 476(9):1353-1368.
PMID: 38570355 PMC: 11310250. DOI: 10.1007/s00424-024-02953-w.
Ruan H, Zhang Q, Zhang Y, Li S, Ran X Crit Care. 2024; 28(1):100.
PMID: 38539163 PMC: 10976824. DOI: 10.1186/s13054-024-04885-4.